Eli Lilly Shares Approach Record High While Retatrutide Legal Action Secures New Obesity Hope

Eli Lilly Shares Approach Record High While Retatrutide Legal Action Secures New Obesity Hope

Shares of Eli Lilly and Company rose 0.5% to $1,226.64 early on Thursday, after six lawsuits were filed over alleged illegal sales of retatrutide, the company's experimental drug for obesity. The stock was trading 1.8% below its peak of $1,249.45.
Nvidia Stock (NVDA) Gains 3% in Premarket Amid Analyst Target $563 Below Current Level—Potential Caution Flag

Nvidia Stock (NVDA) Gains 3% in Premarket Amid Analyst Target $563 Below Current Level—Potential Caution Flag

NVIDIA rose 3.03% on Wednesday, driven by a recovery in AI infrastructure stocks. However, broader investor focus remains on Wall Street's outlook. Analyst price targets now stretch from $180 to $743, with consensus positioned at approximately $314.

Latest